Mutations inducing divergent shifts of constitutive activity reveal different modes of binding among catecholamine analogues to the beta(2)-adrenergic receptor.

1. We compared the changes in binding energy generated by two mutations that shift in divergent directions the constitutive activity of the human beta(2) adrenergic receptor (beta(2)AR). 2. A constitutively activating mutant (CAM) and the double alanine replacement (AA mutant) of catechol-binding serines (S204A, S207A) in helix 5 were stably expressed in CHO cell lines, and used to measure the binding affinities of more than 40 adrenergic ligands. Moreover, the efficacy of the same group of compounds was determined as intrinsic activity for maximal adenylyl cyclase stimulation in wild-type beta(2)AR. 3. Although the two mutations had opposite effects on ligand affinity, the extents of change were in both cases largely correlated with the degree of ligand efficacy. This was particularly evident if the extra loss of binding energy due to hydrogen bond deletion in the AA mutant was taken into account. Thus the data demonstrate that there is an overall linkage between the configuration of the binding pocket and the intrinsic equilibrium between active and inactive receptor forms. 4. We also found that AA mutation-induced affinity changes for catecholamine congeners gradually lacking ethanolamine substituents were linearly correlated to the loss of affinity that such modifications of the ligand cause for wild-type receptor. This indicates that the strength of bonds between catechol ring and helix 5 is critically dependent on the rest of interactions of the beta-ethanolamine tail with other residues of the beta(2)-AR binding pocket.

A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease.

To study factors associated with anemia and its effect on survival in HIV-infected persons treated with modern combined antiretroviral therapy (cART), we characterized the prevalence of anemia in the Veterans Aging Cohort Study (VACS) and used a candidate gene approach to identify proinflammatory gene single nucleotide polymorphisms (SNPs) associated with anemia in HIV disease. The study comprised 1597 HIV(+) and 865 HIV(-) VACS subjects with DNA, blood, and annotated clinical data available for analysis. Anemia was defined according to World Health Organization criteria (hemoglobin < 13 g/dL and < 12 g/dL in men and women, respectively). The prevalence of anemia in HIV(+) and HIV(-) subjects was 23.1% and 12.9%, respectively. Independent of HIV status, anemia was present in 23.4% and 8% in blacks and whites, respectively. Analysis of our candidate genes revealed that the leptin -2548 G/A SNP was associated with anemia in HIV(+), but not HIV(-), patients, with the AA and AG genotypes significantly predicting anemia (P < .003 and P < .039, respectively, logistic regression). This association was replicated in an independent cohort of HIV(+) women. Our study provides novel insight into the association between genetic variability in the leptin gene and anemia in HIV(+) individuals.

Deux dessus de clavecins : [estampe] / gravé par Caylus ; d'après Gillot

Intervenant sur l'exemplaire (autre) : Crépy, Louis (1680?-17..)

Portrait de Watteau, les cheveux courts : [estampe] / gravé par Louis Crépy ; d'après Watteau

Référence bibliographique : Dacier et Vuaflart, 33

Acvbp Versus Acvbp Plus Rituximab For Young Patients With Localized Low-Risk Diffuse Large B-Cell Lymphoma: A Study By The Groupe D'etude Des Lymphomes De L'adulte

Introduction: In a prior study, we demonstrated that ACVBP + consolidation was superior to 3 cycles of CHOP + radiotherapy in young patients (pts) with localized aggressive lymphoma (Reyes F et al. N Engl J Med 2005;352:1197). This randomized trial compared in these pts ACVBP vs. ACVBP + a short course of rituximab (R-ACVBP).Methods: untreated pts between 18 and 65y with stage I/II DLBCL and no adverse prognostic factors according to the aa-IPI were eligible. ACVBP consisted of 3 induction cycles given every 2 weeks: doxorubicin (75 mg/m2) day 1, cyclophosphamide (1.2g/m2) day 1, vindesine (2 mg/m2) day 1 and 5, bleomycin (10 mg) day 1 and 5, prednisone (60 mg/m2) day 1 to 5 followed by consolidation with metothrexate, ifosfamide, VP-16 and cytarabine. R-ACVBP consisted of the same regimen combined with 4 doses of rituximab (375 mg/m2) on day 1, 15, 29 and 43. Primary objective was EFS.Results: From 01/04 to 03/08, 223 pts were randomized, 113 in ACVBP and 110 in R-ACVBP arm. Characteristics were: median age 49y (18-65), stage I 63%, extranodal involvement 45%, bulky disease 4%. CR was 94% in ACVBP and 97% in ACVBP arm (ns). With a median follow-up of 43 months, the 3-y EFS was 82% (95% CI, 73% to 88%) in ACVBP and 93% (95% CI, 87% to 97%) in R-ACVBP group (P=0.0487). The 3-y PFS was 83% (95% CI, 74% to 89%) and 95% (95% CI, 89% to 98%) respectively (P=0.0205). OS did not significantly differ with a 3-y estimates of 97% (95% CI, 90% to 99%) for ACVBP and 98% (95% CI, 92% to 100%) for R-ACVBP (P=0.686). In multivariate analysis, a longer PFS was associated with R-ACVBP arm (P=0.0302) and lower b2-m level (P=0.0164). The same proportion of pts (27%) experienced at least 1 SAE in both groups. There were 4 deaths in each arm, with 1 treatment-related death in R-ACVBP (pneumocystis jiroveci pneumonia).Conclusion: the addition of only 4 doses of rituximab to ACVBP significantly improves EFS and PFS in younger pts with low-risk localized DLBCL.

Extraits de CHRONIQUES, et en particulier de textes relatifs à la NORMANDIE.

Contient : Extrait des Annales S. Dionysii ad cyclos paschales [cf. E. Berger, dans Bibl. de l'Ecole des chartes, t. XL, p. 270] ; Extrait de la chronologie des rois de France, de Bernard Gui, d'après un ms. de Petau, communiqué par Camuzat ; Fragment sur Philippe le Bel, par un moine de Saint-Denis (Frère Ives) [cf. Molinier, Sources, n° 2847] ; Extrait du Chronicon Colmariense [Mon. Germ., SS., t. XVII, p. 240] ; Lettre de Philippe IV relative à la bataille de Mons-en-Pévèle, septembre 1304 ; Fragment (1285-1343) de la chronique de l'Anonyme de Caen [Molinier, n° 1163] ; Extraits historiques relatifs aux fils de Philippe le Bel ; Chartes de Guillaume le Conquérant et d'Henri Ier pour l'abbaye de Montebourg ; Notice de la fondation de ladite abbaye ; Gesta abbatum Fontanellensium, rédaction abrégée. Incipit : « Wandregisilus qui et Wando... » [cf. Archiv, VIII, 373] ; Gesta abbatum Fontanellensium, précédés de la Commemoratio Ansberti [cf. éd. Loewenfeld, Hanovre, 1888, in-8°, et D'Achery, Spicil., éd. in-fol., t. II, p. 263] ; Chartes de l'abbaye de Saint-Wandrille (1024-1177) et extraits de pièces des XIIIe et XIVe siècles relatives à la même abbaye ; Extraits de la chronique de Robert de Thorigny, d'après un ms. du Mont-Saint-Michel ; Extraits d'Annales de Rouen, d'après un ms. de Bigot [ms. lat. 5530 ; cf. L. Delisle, dans Hist. littér., t. XXXII, p. 196] ; Chronologia urbis Rothomagensis (94-1549), composée par M. de La Mare ; Chron. Nortmannorum [cf. Duchesne, Rer. Franc. scriptores, t. II, p. 524, et L. Delisle, dans Notices et extraits, t. XXXVIII, p. 697] ; Annales de Saint-Wandrille, dites Chronicon Thosanum, [cf. Hist. littér., t. XXXII, p. 204] ; Eloge en vers de Lanfranc [Mabillon, AA. SS. Ben., t. VI, II, p. 659], d'après un ms. de Saint-Florent-lès-Saumur ; Trêve de Dieu pour la Normandie, du temps de Gullaume le Conquérant ; Extrait d'un ms. intitulé « Cursus Normanniae », communiqué par J. Sirmond ; Notice sur les abbés de Fécamp, jusqu'à Henri de Lorraine (1613-1642), d'après un ms. de M. de la Meschinière ; Catalogue des abbés du même monastère jusqu'à François de Joyeuse (1600-1613) ; Extraits d'un cartulaire de Saint-Michel du Tréport ; Extraits d'un calendrier de la même abbaye ; Extraits de la vie de saint Exupère, évêque de Bayeux ; Vers sur l'abbaye de Jumièges, attribués au moine Adrien (cf. Frère, Bibliogr. normand, t. I, p. 154) ; Extraits d'un calendrier des chanoines d'Eu ; Liste des évêques de Lisieux jusqu'à Guillaume Du Vair (1618-1621) ; Evêques de Bayeux jusqu'à Jacques d'Angennes (1606-1647) ; Evêques de Coutances jusqu'à Nicolas de Briroi (1589-1620) ; Evêques d'Evreux jusqu'à François de Péricard (1613-1646) ; Notes sur les chartes de l'abbaye de Savigny ; Chartes du Breuil-Benoît ; Catalogue des abbés de Jumièges ; Fondation de l'abbaye de Blanchelande (1154), et extraits des chartes de ce monastère ; Notes sur le fouage à lever en Normandie et sur les forteresses occupées par le roi, d'après les registres du Trésor des chartes ; Extraits des archives de Notre-Dame d'Ardenne ; Extraits des archives de Saint-Etienne de Caen ; Chartes diverses relatives à la Normandie (1217-1262) ; Annales d'Avranches, 837-1359 [cf. Hist. de Fr., t. XXIII, p. 568] ; Extraits de deux rédactions de la Vita Vanengi [Bibl. hag. lat., 8811 et 8813] ; Traité entre Abu-Issac et Vibaldus, envoyé de l'empereur Frédéric II (1231), traduction latine par M. Obelius Cicero [Mon. Germ., Const., t. II, p. 187] ; Extraits de chroniques arabes relatifs à l'histoire de Sicile, traduits par le même

Comparison of three acellular tests for assessing the oxidation potential of nanomaterials

Great effort is put into developing reliable, predictive, high-throughput, and low-cost screening approaches for the toxicity evaluation of ambient and manufactured nanoparticles (NP). These tests often consider oxidative reactivity, as oxidative stress is a well-documented pathway in particle toxicology. Based on a panel of six carbonaceous and five metal/metal oxide (Me/MeOx) nanoparticles, we: (i) compared the specifications (linearity, detection limits, repeatability) of three acellular reactivity tests using either dithiothreitol (DTT assay), dichlorofluorescein (DCFH assay), or ascorbic acid (AA-assay) as the reducing agent; and (ii) evaluated which physicochemical properties were important for explaining the observed reactivity. The selected AA assay was found to be neither sensitive nor robust enough to be retained. For the other tests, the surface properties of carbonaceous NP were of utmost importance for explaining their reactivity. In particular, the presence of "strongly reducing" surface functions explained most of its DCFH reactivity and a large part of its DTT reactivity. For the selected Me/MeOx, a different picture emerged. Whereas all particles were able to oxidize DCFH, dissolution and complexation processes could additionally influence the measured reactivity, as observed using the DTT assay. This study suggests that a combination of the DTT and DCFH assays provides complementary information relative to the quantification of the oxidative capacity of NP.

Dietary supplementation with omega-3 in cystic fibrosis patients

Accumulation of neutr ophils releasing proteolytic enzymes and free radicals induceprogressive lung tissue destruction in CF. Among several hfflammatory mediatorsimplicated in this process, leukotriene B 4 (LTB4) product of arachidonic (AA;20:4n 6) omega 6 polytmsaturated fatty acid (PUFA) plays an important role.Various anti inflammatory strategies including dietary supplementation of omega 3PUFA, known to favor the synthesis of less active leukotriene B 5 (LTBs), have beeninvestigated. To further explore this nutritional approach, biological effects of anomega 3 PUFA oral supplementation (n 3 OS) were measured in 17 CF patients haa prospective, randomized, double blind, crossover study. CF patients (mean age:18 + 9 years, FEVI: 66 + 29 %) received a dietary supplementation enriched, or not,ha omega 3 PUFA during a 2 x 6 months period. A modification in neutrophilmembrane PUFA composition was observed under n 3 OS with an increase in EPA(20:5n 3) PUFA (from 0.66 ± 0.56 to 1.60 ± 0.61 ~tmol %, P< 0.01). The LTB jLTB 5ratio was decreased (from 72 + 27 to 24 + 7, P< 0.C~31), in CF patients taking n 3OS. However, n 3 OS supplementation did neither affect the internalization of bothIL 8 receptors following IL 8 exposure, nor IL 8 induced neutrophil chemotaxis.Our results show that n 3 PUFA are absorbed and incorporated in neutrophilmembrmae. The consecutive decrease ha LTBjLTB 5 ratio suggests that, ha theseconditions, neutr ophils may produce less toxic mediators from the AA pathway. Thepotential clinical benefit for CF patients still needs to be assessed with furtherstudies of longer duration and including more patients.

Vitamina C, Cancro e Cittoxidade: Marcação e estabilidade in vitro e in vivo

A vitamina C é uma substância essencial apresentando inúmeras propriedades fisiológicas. Ela apresenta-se sob duas formas, a reduzida e a oxidada. O ácido ascórbico (AA), a forma reduzida da vitamina C, é um potente antioxidante hidrossolúvel, na medida em que neutraliza os radicais livres, constituindo um potencial mecanismo anticancerígeno. O AA actua também como pró-oxidante, promovendo a formação de espécies reactivas de oxigénio (ROS), como o peróxido de hidrogénio (H2O2), que comprometem a viabilidade celular. Por outro lado, a maioria das células tumorais não transporta directamente o AA para o seu interior, razão pela qual as células obtêm a vitamina C na sua forma oxidada, o ácido dehidroascórbico (DHA). As células tumorais demonstram ainda outra particularidade, a diminuição da catalase (enzima responsável pela destoxificação do H2O2), num factor entre 10 e 100, relativamente às células normais. Assim, o aumento da produção de H2O2, acoplado à deficiência da actividade da catalase nas células neoplásicas e à presença de metais de transição, poderá redundar na citotoxicidade selectiva da vitamina C e na consequente revelação do seu potencial terapêutico.

Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms.

BACKGROUND: High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor outcome following interferon/ribavirin therapy in patients with chronic hepatitis C. Several recent studies report that single nucleotide polymorphisms (SNPs) adjacent to IL28B predict spontaneous resolution of HCV infection and outcome of treatment among HCV genotype 1 infected patients. METHODS AND FINDINGS: In the present study, we correlated the occurrence of variants at three such SNPs (rs12979860, rs12980275, and rs8099917) with pretreatment plasma IP-10 and HCV RNA throughout therapy within a phase III treatment trial (HCV-DITTO) involving 253 Caucasian patients. The favorable SNP variants (CC, AA, and TT, respectively) were associated with lower baseline IP-10 (P = 0.02, P = 0.01, P = 0.04) and were less common among HCV genotype 1 infected patients than genotype 2/3 (P<0.0001, P<0.0001, and P = 0.01). Patients carrying favorable SNP genotypes had higher baseline viral load than those carrying unfavorable variants (P = 0.0013, P = 0.029, P = 0.0004 respectively). Among HCV genotype 1 infected carriers of the favorable C, A, or T alleles, IP-10 below 150 pg/mL significantly predicted a more pronounced reduction of HCV RNA from day 0 to 4 (first phase decline), which translated into increased rates of RVR (62%, 53%, and 39%) and SVR (85%, 76%, and 75% respectively) among homozygous carriers with baseline IP-10 below 150 pg/mL. In multivariate analyses of genotype 1-infected patients, baseline IP-10 and C genotype at rs12979860 independently predicted the first phase viral decline and RVR, which in turn independently predicted SVR. CONCLUSIONS: Concomitant assessment of pretreatment IP-10 and IL28B-related SNPs augments the prediction of the first phase decline in HCV RNA, RVR, and final therapeutic outcome.

Arythmies supraventriculaires chez les patients adultes porteurs d'une cardiopathie congénitale

Mon projet de recherche s'est articulé autour des arythmies supraventriculaires chez les patients adultes porteurs d'une cardiopathie congénitale (Adults with Congenital Heart Disease ou ACHD). Grâce aux progrès de la chirurgie cardiaque et de la cardiologie, la survie à l'âge adulte des enfants nés avec une malformation cardiaque est excellente et la population des ACHD ne cesse de croître, tout en vieillissant. Les arythmies cardiaques sont une complication à long terme bien connue chez ces patients et une des principales causes de mortalité et de morbidité. Mon travail de recherche comporte une perspective épidémiologique avec une étude de population et une perspective anatomique, avec une étude d'imagerie cardiaque par échographie. 1. Étude épidémiologique : Arythmies auriculaires (AA) chez les patients porteurs d'une cardiopathie congénitale. Sous le titre anglais Atrial Arrhythmias in Adults with Congenital Heart Disease, cette étude a été publiée dans le journal américain Circulation. A travers les résultats de cette étude, j'ai démontré, pour la première fois dans une aussi grande population, que les AA étaient fréquentes chez les patients ACHD, que le risque à long-terme pour ces patients de développer des AA était élevé, et que le développement d'AA avait un impact négatif en termes de mortalité, de morbidité et d'intervention. 2. Étude anatomique : Les paramètres échographiques associés à la fibrillation auriculaire (FA) chez les patients adultes porteurs d'une cardiopathie congénitale. Sous le titre anglais Mirror image atrial dilatation in Adult Patients with Atrial Fibrillation and Congenital Heart Disease, cette étude a été publiée dans le journal américain International Journal of Cardiology, j'ai démontré dans cette étude que les patients ACHD avec une pathologie isolée du coeur gauche présentaient une dilatation progressive de l'oreillette gauche (OG) lorsqu'ils développaient de la FA. Chez les patients avec une pathologie isolée du coeur droit, j'ai décrit une image « miroir » : l'oreillette droite (OD) était toujours plus grande que l'OG βί présentait une dilatation progressive lors de FA. Ces résultats soutiennent l'hypothèse que la FA pourrait provenir de l'OD dilatée chez les patients ACHD avec une pathologie du coeur droit et ouvrent de nouvelles perspectives diagnostiques et thérapeutiques chez ces patients:

Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosy.

Accumulating evidence suggests that polymorphisms in Toll-like receptors (TLRs) influence the pathogenesis of mycobacterial infections, including leprosy, a disease whose manifestations depend on host immune responses. Polymorphisms in TLR2 are associated with an increased risk of reversal reaction, but not susceptibility to leprosy itself. We examined whether polymorphisms in TLR4 are associated with susceptibility to leprosy in a cohort of 441 Ethiopian leprosy patients and 197 healthy controls. We found that two single nucleotide polymorphisms (SNPs) in TLR4 (896G>A [D299G] and 1196C>T [T399I]) were associated with a protective effect against the disease. The 896GG, GA and AA genotypes were found in 91.7, 7.8 and 0.5% of leprosy cases versus 79.9, 19.1 and 1.0% of controls, respectively (odds ratio [OR] = 0.34, 95% confidence interval [CI] 0.20-0.57, P < 0.001, additive model). Similarly, the 1196CC, CT and TT genotypes were found in 98.1, 1.9 and 0% of leprosy cases versus 91.8, 7.7 and 0.5% of controls, respectively (OR = 0.16, 95% CI 0.06--.40, P < 0.001, dominant model). We found that Mycobacterium leprae stimulation of monocytes partially inhibited their subsequent response to lipopolysaccharide (LPS) stimulation. Our data suggest that TLR4 polymorphisms are associated with susceptibility to leprosy and that this effect may be mediated at the cellular level by the modulation of TLR4 signalling by M. leprae.

Affirmative Action in Iowa, September 2007

In accordance with 19B.5 of the Code of Iowa, the 2007 Affirmative Action in Iowa report illustrates the progress made during fiscal year 2007 to balance the State's workforce, the challenges that the State must address and the effort that the Department of Administrative Services must lead in order to remove barriers that limit the hiring, retention and advancement of females, minorities and persons with disabilities in the State's workforce. Highlighted in the report are the State's efforts to improve EEO/AA/Diversity training, coordinating targeted recruitment and partnering with disability organizations. Additionally, the Department of Administrative Services-Human Resources Enterprise outlines its plan to build on its past efforts and implement recommendations to remove barriers in the state selection processes and to improve its affirmative action and auditing processes.